Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma
Chengjie Zhong,Jiajiu Chen,Yi Ling,Deng Liu,Jing Xu,Luofu Wang,Chengguo Ge,Qing Jiang
DOI: https://doi.org/10.2147/IJN.S408977
IF: 7.033
2023-05-24
International Journal of Nanomedicine
Abstract:Chengjie Zhong, 1, &ast Jiajiu Chen, 2, &ast Yi Ling, 3 Deng Liu, 3 Jing Xu, 2 Luofu Wang, 2 Chengguo Ge, 4 Qing Jiang 4 1 The Second Clinical Medical College, Chongqing Medical University, Chongqing, 400016, People's Republic of China; 2 Department of Urology, Daping Hospital, Army Medical University, Chongqing, 400038, People's Republic of China; 3 Department of Ultrasound, Southwest Hospital, Army Medical University, Chongqing, 400042, People's Republic of China; 4 Department of Urology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chengguo Ge; Qing Jiang, Department of Urology, the Second Affiliated Hospital, Chongqing Medical University, Chongqing, 400010, People's Republic of China, Tel +86 13883510963 ; +86 13508346066, Email ; Background and Purpose: The early diagnosis and differential diagnosis of renal cell carcinoma (RCC) has always been a clinical difficulty and a research focus. Carbonic anhydrase IX (CA IX) is highly expressed on the cell membrane of RCC but is not expressed in normal renal tissues. In this study, nanobubbles (NBs) targeting CA IX with ultrasound and photoacoustic multimodal imaging capabilities were prepared to explore a new method for the diagnosis and differential diagnosis of RCC. Methods: Indocyanine green (ICG)-loaded lipid NBs (ICG-NBs) were prepared by using the filming rehydration method, and anti-CA IX polypeptides (ACPs) were attached to their surfaces to prepare CA IX-targeted NBs (ACP/ICG-NBs). The particle size, zeta potential and ICG encapsulation efficiency of these nanobubbles were measured, and their specific targeting and binding abilities to RCC cells were determined. The in vitro and in vivo ultrasound, photoacoustic and fluorescence imaging characteristics of these nanobubbles were also assessed. Results: The particle size of the ACP/ICG-NBs was 475.9 nm in diameter, and their zeta potential was − 2.65 mV. Laser confocal microscopy and flow cytometry both confirmed that ACP/ICG-NBs had specific binding activity and ideal affinity to CA IX-positive RCC cells (786-O) but not to CA IX-negative RCC cells (ACHN). The intensities of the in vitro ultrasound, photoacoustic and fluorescence imaging were positively correlated with the concentrations of ACP/ICG-NBs. In in vivo ultrasound and photoacoustic imaging experiments, ACP/ICG-NBs exhibited specific enhanced ultrasound and photoacoustic imaging effects in 786-O xenograft tumors. Conclusion: The ICG- and ACP-loaded targeted nanobubbles that we prepared had the capability of ultrasound, photoacoustic and fluorescence multimodal imaging and could specifically enhance the ultrasound and photoacoustic imaging of RCC xenograft tumors. This outcome has potential clinical application value for the diagnosis of RCC at the early stage and the differential diagnosis of benign and malignant kidney tumors. Keywords: contrast-enhanced ultrasound imaging, photoacoustic imaging, renal cell carcinoma, carbonic anhydrase IX, targeted nanobubble, fluorescence imaging Renal cell carcinoma (RCC) originates from renal tubular epithelial cells and is responsible for approximately 90% of all renal malignancies. 1,2 However, due to the deep location of the kidney, the early clinical manifestations of RCC are insidious, and the patients exhibit no obvious symptoms. More than 16% of patients develop distant metastasis at the time of the initial diagnosis. 3 At present, the diagnosis of RCC mainly relies on imaging examinations, including color Doppler ultrasound, computerized tomography (CT, including enhanced CT) and magnetic resonance imaging (MRI). 4 In fact, it is not difficult to detect renal tumors via imaging examinations; however, the differentiation between benign and malignant tumors (especially small renal tumors) often makes it difficult to provide clear conclusions due to the lack of specificity. It is not uncommon for benign tumors to be misdiagnosed as RCC, and nephrectomy is subsequently performed. 5,6 Therefore, the early and accurate diagnosis of RCC and differential diagnosis of benign and malignant renal tumors are still clinical difficulties and research priorities. Color Doppler ultrasonography is the preferred method for the diagnosis of renal space-occupying lesions. 7 It has the characteristics of high resolution, a lack of radiation and real-time dynamic observations. However, conventional color Doppler ultrasonography is not ideal for tumor characterization. Contrast-enhanced ultrasound -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology